Isoliquiritigenin limits inflammasome activation of macrophage via docking into Syk to alleviate murine non‐alcoholic fatty liver disease

Xiangyu Hu(Yangzhou University), Weijuan Gong(Yangzhou University), Liting Liao(Yangzhou University), Xingmeng Xu(Yangzhou University), Jie Xiang(Yangzhou University), Chunmiao Hu(Kunming Institute of Zoology), Huimin Zhang(Yangzhou University), Xiaoqin Jia(Yangzhou University), Hongwei Xu(Shanghai University of Traditional Chinese Medicine), Guotao Lu(Harbin Medical University)
Scandinavian Journal of Immunology
April 26, 2024
Cited by 5


Related Papers